New treatment plan drops hospitalizations, deaths of some transplant recipients with COVID-19

Liver and kidney transplant recipients have a higher risk of severe COVID-19 and/or death should they become infected because the medication they take to ensure a successful transplant suppresses their immune systems.

Keck Hospital of USC performs some 300 Read More »

October 14th, 2021|Announcements, COVID-19, Keck Net Intranet|

Armand Dorian named CEO of USC Verdugo Hills Hospital

Armand Dorian, MD, MMM, has been named CEO of USC Verdugo Hills Hospital (USC-VHH), part of Keck Medicine of USC. He has served as interim CEO since March 2021 and will begin his Read More »

October 13th, 2021|Announcements, Keck Net Intranet|

USC Stevens INI receives large award to harmonize Alzheimer’s research data

The USC Mark and Mary Stevens Neuroimaging and Informatics Institute (USC Stevens INI) is one of three institutions partnering in a five-year, $31.7 million grant from the National Institutes of Health (NIH) to merge many types of Read More »

October 13th, 2021|Announcements, Keck Net Intranet|

NIH awards $10 million for pediatric concussion research

The National Institute of Neurological Disorders and Stroke has awarded a $10 million grant to a consortium of academic institutions focused on identifying the best diagnostic techniques for predicting recovery and long-term consequences of concussion among children. Researchers at the Read More »

October 12th, 2021|Announcements, Keck Net Intranet|

USC Norris launches global clinical trial testing potential therapy for aggressive type of breast cancer

USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, has launched a global registration, phase 2 clinical trial investigating the efficacy of a potential new breast cancer therapy called ARX788.

The trial is Read More »

October 11th, 2021|Announcements, Keck Net Intranet|